Nequinate

CAS No. 13997-19-8

Nequinate( —— )

Catalog No. M21639 CAS No. 13997-19-8

Nequinate is an anticoccidial agent preventing coccidiosis .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 Get Quote
10MG 53 Get Quote
25MG 87 Get Quote
50MG 140 Get Quote
100MG 222 Get Quote
200MG 331 Get Quote
500MG 536 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Nequinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Nequinate is an anticoccidial agent preventing coccidiosis .
  • Description
    Nequinate is an anticoccidial agent preventing coccidiosis .
  • In Vitro
    Xanthine oxidase (XOD) is a successful and safe drug target for lowering lower serum urate (sUA) levels , it plays an important role in the catabolism of purineNequinate shows an inhibition of 12.0% to inhibit XOD activities.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13997-19-8
  • Formula Weight
    365.43
  • Molecular Formula
    C22H23NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCc1cc2c(cc1OCc1ccccc1)[nH]cc(C(=O)OC)c2=O
  • Chemical Name
    Methyl 6-butyl-4-oxo-7-phenylmethoxy-1H-quinoline-3-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Takayuki Nakajima Hiroshiet al. [Determination of nequinate and buquinolate in livestock products using liquid chromatography-tandem mass spectrometry].[J]. Shokuhinseigaku Zasshi Journal of the Food Hygienic Society of Japan 2011.
molnova catalog
related products
  • D-(+)-Maltose monohy...

    A dextrodisaccharide from malt and starch. It is used as a sweetening agent and fermentable intermediate in brewing.

  • Ganoderenic acid A m...

    Ganoderenic acid A methyl ester

  • NMS-P937

    NMS-P937 (NMS1286937), an oral, specific Polo-like Kinase 1 (PLK1) inhibitor, is with IC50 of 2 nM. The specificity of NMS-P937 forPLK1 is 5000-fold higher over PLK2/PLK3.